NES
NPSP

New England Securities’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

New England Securities’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$222K Buy
6,195
+200
+3% +$5.97K 0.08% 253
2014
Q3 		$156K Buy
5,995
+400
+7% +$11.5K 0.05% 332
2014
Q2 		$185K Buy
5,595
+390
+7% +$11.3K 0.06% 323
2014
Q1 		$156K Buy
5,205
+440
+9% +$15.2K 0.06% 305
2013
Q4 		$145K Buy
4,765
+1,180
+33% +$32.5K 0.06% 323
2013
Q3 		$114K Sell
3,585
-200
-5% -$4.59K 0.06% 322
2013
Q2 		$57K Buy
+3,785
New +$52.4K 0.04% 402

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

New England Securities's NPSP Position: Q4 2014 in Review

New England Securities increased its NPS PHARMACEUTICALS INC (NPSP) stake by 3.3% in Q4 2014, buying an estimated $5.97K and bringing the position to 6,195 shares worth $222K. The position accounts for 0.08% of the portfolio, ranked #253.

New England Securities first reported a position in NPSP in Q2 2013 and has held it in 7 quarters since. 213 funds tracked by Wall St. Rank hold NPSP as of Q4 2014.

  • New England Securities held 6,195 shares of NPS PHARMACEUTICALS INC worth $222K as of Q4 2014.
  • New England Securities bought 200 NPS PHARMACEUTICALS INC shares in Q4 2014, an estimated $5.97K.
  • NPS PHARMACEUTICALS INC made up 0.08% of New England Securities's portfolio in Q4 2014, its #253 holding.
  • New England Securities first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and has held it in 7 quarters since.
  • 213 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.